See more : Cyclo Therapeutics, Inc. (CYTHW) Income Statement Analysis – Financial Results
Complete financial analysis of Tibet Rhodiola Pharmaceutical Holding Co. (600211.SS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Tibet Rhodiola Pharmaceutical Holding Co., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Aluminum Corporation of China Limited (ACHHY) Income Statement Analysis – Financial Results
- Celyad Oncology SA (CYAD.BR) Income Statement Analysis – Financial Results
- Bechtle AG (BHTLF) Income Statement Analysis – Financial Results
- KGI Securities (Thailand) Public Company Limited (KGI.BK) Income Statement Analysis – Financial Results
- Hypefactors A/S (HYPE.CO) Income Statement Analysis – Financial Results
Tibet Rhodiola Pharmaceutical Holding Co. (600211.SS)
About Tibet Rhodiola Pharmaceutical Holding Co.
Tibet Rhodiola Pharmaceutical Holding Co. engages in the research and development, production, and sale of pharmaceuticals in China and internationally. It offers biological products, Tibetan medicine, Chinese medicine, and chemical medicine products. The company was founded in 1999 and is based in Lhasa, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.13B | 2.55B | 2.14B | 1.37B | 1.26B | 1.03B | 915.63M | 796.81M | 1.38B | 1.67B | 1.40B | 1.22B | 1.08B | 1.11B | 1.11B | 991.07M | 823.24M | 861.84M | 696.48M | 182.66M | 75.08M | 74.49M | 74.66M | 83.12M | 82.97M | 78.05M | 48.29M | 21.66M |
| Cost of Revenue | 155.08M | 146.69M | 223.22M | 194.96M | 206.64M | 206.37M | 239.58M | 188.58M | 935.46M | 1.33B | 1.12B | 978.01M | 885.17M | 918.83M | 921.12M | 841.52M | 722.22M | 639.17M | 578.52M | 98.95M | 17.63M | 13.96M | 9.56M | 13.76M | 15.83M | 10.90M | 8.64M | 5.15M |
| Gross Profit | 2.98B | 2.41B | 1.92B | 1.18B | 1.05B | 821.51M | 676.05M | 608.23M | 447.29M | 339.72M | 279.76M | 243.37M | 193.87M | 191.89M | 188.50M | 149.55M | 101.01M | 222.67M | 117.96M | 83.71M | 57.45M | 60.53M | 65.10M | 69.36M | 67.13M | 67.15M | 39.65M | 16.51M |
| Gross Profit Ratio | 95.05% | 94.26% | 89.56% | 85.80% | 83.55% | 79.92% | 73.83% | 76.33% | 32.35% | 20.37% | 19.95% | 19.93% | 17.97% | 17.28% | 16.99% | 15.09% | 12.27% | 25.84% | 16.94% | 45.83% | 76.52% | 81.26% | 87.20% | 83.44% | 80.92% | 86.03% | 82.10% | 76.23% |
| Research & Development | 17.35M | 88.13M | 60.86M | 7.46M | 11.07M | 8.21M | 4.16M | 7.48M | 4.16M | 2.82M | 2.69M | 1.38M | 3.65M | 1.62M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 48.93M | 47.75M | 44.44M | 34.65M | 31.77M | 27.93M | 24.83M | 16.54M | 14.08M | 18.38M | 13.18M | 12.83M | 13.86M | 13.38M | 33.91M | 32.40M | 43.16M | 37.96M | 56.06M | 27.37M | 20.67M | 16.45M | 16.36M | 13.25M | 8.66M | 3.69M | 2.76M | 2.06M |
| Selling & Marketing | 1.75B | 1.41B | 1.15B | 684.56M | 623.04M | 484.29M | 376.87M | 357.12M | 315.53M | 246.25M | 207.41M | 180.71M | 138.04M | 132.30M | 147.19M | 103.90M | 144.13M | 183.77M | 93.69M | 52.86M | 37.70M | 34.24M | 32.50M | 27.51M | 28.29M | 30.52M | 16.52M | 7.89M |
| SG&A | 1.88B | 1.46B | 1.20B | 719.21M | 654.81M | 512.22M | 401.70M | 373.67M | 329.61M | 264.63M | 220.59M | 193.54M | 151.90M | 145.68M | 181.10M | 136.30M | 187.29M | 221.74M | 149.75M | 80.23M | 58.38M | 50.69M | 48.87M | 40.76M | 36.95M | 34.21M | 19.28M | 9.95M |
| Other Expenses | 177.76M | 110.87M | 78.76M | -7.39M | 38.57M | -20.05M | 48.12M | 32.50M | -189.07K | 1.32M | 21.46M | 22.53M | 17.51M | 17.65M | 14.86M | 9.89M | 11.36M | 17.57M | 5.91M | 7.92M | 3.31M | 4.56M | 2.46M | 5.22M | 6.04M | 2.40M | 752.42K | -247.66K |
| Operating Expenses | 2.08B | 1.66B | 1.34B | 719.27M | 704.46M | 500.37M | 414.60M | 411.30M | 373.60M | 308.22M | 256.98M | 221.14M | 181.56M | 173.18M | 184.65M | 138.48M | 188.84M | 224.29M | 151.31M | 81.25M | 58.56M | 50.81M | 48.97M | 40.86M | 37.15M | 34.40M | 19.31M | 9.98M |
| Cost & Expenses | 2.24B | 1.80B | 1.56B | 914.24M | 911.10M | 706.75M | 654.18M | 599.88M | 1.31B | 1.64B | 1.38B | 1.20B | 1.07B | 1.09B | 1.11B | 980.00M | 911.07M | 863.46M | 729.83M | 180.21M | 76.18M | 64.78M | 58.53M | 54.62M | 52.98M | 45.30M | 27.95M | 15.13M |
| Interest Income | 45.78M | 14.32M | 2.67M | 11.43M | 14.57M | 12.31M | 25.47M | 6.29M | 10.24M | 9.83M | 4.51M | 4.41M | 1.90M | 1.67M | -0.32 | -0.55 | -0.14 | 2.70M | 1.18M | 10.11M | 7.58M | 5.83M | 3.90M | 3.44M | 0.00 | -0.15 | -0.86 | -0.40 |
| Interest Expense | 11.59M | 14.36M | 4.33M | 1.05M | 1.06M | 274.29K | 18.37M | 12.10M | 4.66M | 6.20M | 11.16M | 10.49M | 5.73M | 5.98M | 4.94M | 10.13M | 11.77M | 13.96M | 15.32M | 11.96M | 12.86M | 10.36M | 5.31M | 380.77K | 0.00 | 3.21M | 1.21M | 683.77K |
| Depreciation & Amortization | 68.05M | 70.79M | 82.13M | 77.95M | 76.88M | 74.93M | 75.58M | 55.61M | 12.49M | 16.36M | 17.33M | 16.16M | 15.60M | 15.51M | 14.02M | 15.37M | 20.06M | 19.68M | 17.12M | 12.62M | 11.38M | 4.92M | 3.78M | 3.43M | 2.73M | 2.25M | 896.31K | 683.77K |
| EBITDA | 976.16M | 551.19M | 351.31M | 558.10M | 433.15M | 321.24M | 359.52M | 292.40M | 126.84M | 49.08M | 58.57M | 59.17M | 44.72M | 51.53M | 42.04M | 26.44M | -67.77M | 35.81M | -10.16M | 30.66M | 29.93M | 25.43M | 27.32M | 34.61M | 32.71M | 32.75M | 20.34M | 6.53M |
| EBITDA Ratio | 31.14% | 32.77% | 30.24% | 39.88% | 34.46% | 39.69% | 39.65% | 36.53% | 8.91% | 3.45% | 4.74% | 5.52% | 4.32% | 4.81% | 1.19% | 3.46% | -2.97% | 4.22% | -1.46% | 16.77% | 39.86% | 34.14% | 36.59% | 47.83% | 39.43% | 41.96% | 42.11% | 30.14% |
| Operating Income | 899.09M | 768.03M | 565.25M | 472.12M | 351.22M | 331.47M | 213.48M | 189.79M | 106.65M | 25.64M | 8.66M | 9.54M | 5.96M | 12.34M | 7.64M | -4.16M | -137.36M | -13.63M | -48.35M | 26.43K | 4.75M | 8.11M | 18.63M | 33.59M | 32.32M | 30.50M | 19.44M | 5.84M |
| Operating Income Ratio | 28.69% | 30.06% | 26.43% | 34.38% | 27.96% | 32.25% | 23.32% | 23.82% | 7.71% | 1.54% | 0.62% | 0.78% | 0.55% | 1.11% | 0.69% | -0.42% | -16.69% | -1.58% | -6.94% | 0.01% | 6.32% | 10.89% | 24.95% | 40.41% | 38.95% | 39.08% | 40.26% | 26.98% |
| Total Other Income/Expenses | -898.13K | 962.27K | -300.71M | -1.80M | 1.44M | 382.70K | 48.12M | 32.50M | -321.54K | 872.14K | 21.44M | 22.51M | 17.43M | 17.63M | 14.79M | -5.37M | -41.61M | 16.00M | -9.48M | 6.03M | 941.08K | 2.03M | -394.63K | 819.63K | 5.06M | 1.43M | 438.47K | -247.66K |
| Income Before Tax | 898.19M | 463.39M | 254.85M | 470.32M | 352.67M | 244.44M | 261.60M | 222.03M | 106.33M | 26.51M | 30.10M | 32.05M | 23.42M | 29.97M | 22.45M | 5.70M | -129.44M | 2.75M | -42.63M | 6.06M | 5.69M | 10.14M | 18.24M | 35.95M | 37.38M | 31.93M | 19.88M | 5.60M |
| Income Before Tax Ratio | 28.66% | 18.14% | 11.92% | 34.25% | 28.08% | 23.78% | 28.57% | 27.87% | 7.69% | 1.59% | 2.15% | 2.62% | 2.17% | 2.70% | 2.02% | 0.58% | -15.72% | 0.32% | -6.12% | 3.32% | 7.58% | 13.62% | 24.43% | 43.25% | 45.05% | 40.91% | 41.16% | 25.84% |
| Income Tax Expense | 87.95M | 88.11M | 41.82M | 49.65M | 35.30M | 26.35M | 27.31M | 22.64M | 15.59M | 6.30M | 6.14M | 1.55M | 2.34M | 5.79M | 1.61M | -155.30K | 783.73K | 294.69K | 228.53K | 62.73K | 17.20M | 8.21M | 4.50M | 221.55K | 4.30M | -3.21M | -1.21M | -683.77K |
| Net Income | 800.91M | 369.84M | 208.94M | 418.10M | 312.32M | 215.61M | 229.65M | 198.29M | 91.64M | 20.98M | 27.15M | 30.53M | 20.51M | 23.56M | 19.09M | 6.49M | -125.27M | 3.08M | -41.32M | 6.08M | 5.77M | 10.20M | 18.30M | 35.72M | 33.07M | 31.93M | 19.88M | 5.60M |
| Net Income Ratio | 25.55% | 14.48% | 9.77% | 30.45% | 24.87% | 20.98% | 25.08% | 24.89% | 6.63% | 1.26% | 1.94% | 2.50% | 1.90% | 2.12% | 1.72% | 0.65% | -15.22% | 0.36% | -5.93% | 3.33% | 7.69% | 13.69% | 24.51% | 42.97% | 39.87% | 40.91% | 41.16% | 25.84% |
| EPS | 2.48 | 1.49 | 0.84 | 1.69 | 1.25 | 0.86 | 0.98 | 0.97 | 0.45 | 0.10 | 0.14 | 0.15 | 0.10 | 0.11 | 0.11 | 0.03 | -0.58 | 0.02 | -0.15 | 0.02 | 0.02 | 0.04 | 0.07 | 0.12 | 0.13 | 0.12 | 0.07 | 0.02 |
| EPS Diluted | 2.48 | 1.49 | 0.84 | 1.69 | 1.25 | 0.86 | 0.98 | 0.97 | 0.45 | 0.10 | 0.14 | 0.15 | 0.10 | 0.11 | 0.11 | 0.03 | -0.58 | 0.02 | -0.15 | 0.02 | 0.02 | 0.04 | 0.07 | 0.12 | 0.13 | 0.12 | 0.07 | 0.02 |
| Weighted Avg Shares Out | 322.35M | 247.94M | 247.94M | 247.94M | 249.86M | 251.47M | 235.53M | 203.82M | 203.64M | 203.89M | 200.08M | 203.53M | 205.14M | 206.12M | 188.56M | 199.78M | 214.35M | 209.80M | 275.03M | 275.03M | 275.03M | 275.03M | 275.03M | 275.03M | 275.03M | 275.03M | 275.03M | 275.03M |
| Weighted Avg Shares Out (Dil) | 322.35M | 247.94M | 247.94M | 247.94M | 249.86M | 251.54M | 235.53M | 204.12M | 203.64M | 209.80M | 200.08M | 203.53M | 205.14M | 206.12M | 188.56M | 199.78M | 214.35M | 209.80M | 275.03M | 275.03M | 275.03M | 275.03M | 275.03M | 275.03M | 275.03M | 275.03M | 275.03M | 275.03M |
No news found for: 600211.SS
Source: https://incomestatements.info
Category: Stock Reports